Miller Investment Management LP Reduces Position in iShares Biotechnology ETF (NASDAQ:IBB)

Miller Investment Management LP reduced its position in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 1.8% in the 3rd quarter, Holdings Channel.com reports. The firm owned 82,563 shares of the financial services provider’s stock after selling 1,521 shares during the period. iShares Biotechnology ETF comprises about 1.3% of Miller Investment Management LP’s holdings, making the stock its 21st largest position. Miller Investment Management LP’s holdings in iShares Biotechnology ETF were worth $12,021,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently modified their holdings of IBB. Darwin Wealth Management LLC purchased a new stake in iShares Biotechnology ETF during the 3rd quarter worth about $29,000. Highline Wealth Partners LLC purchased a new stake in shares of iShares Biotechnology ETF during the 3rd quarter worth approximately $30,000. Bbjs Financial Advisors LLC purchased a new position in shares of iShares Biotechnology ETF in the 2nd quarter valued at $31,000. Ashton Thomas Securities LLC acquired a new stake in iShares Biotechnology ETF during the 3rd quarter worth $36,000. Finally, Voisard Asset Management Group Inc. purchased a new stake in iShares Biotechnology ETF in the third quarter valued at $59,000. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Trading Down 1.2 %

IBB opened at $140.00 on Wednesday. iShares Biotechnology ETF has a one year low of $121.84 and a one year high of $150.57. The business’s 50-day simple moving average is $142.53 and its 200-day simple moving average is $142.14.

iShares Biotechnology ETF Announces Dividend

The company also recently disclosed a dividend, which was paid on Monday, September 30th. Shareholders of record on Wednesday, September 25th were paid a $0.2005 dividend. The ex-dividend date was Wednesday, September 25th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.